Research
The Brett Boyer Foundation is thrilled to highlight a few research projects, past and present, we are funding. Because of your support, advancements are being made in treatment for Congenital Heart Disease. We encourage you to read more about these exciting projects.
This research initiative is a continuation of the project initially funded in 2022 by The Brett Boyer Foundation and is focused on advancing progress made-to-date.
We hypothesize that a profile of plasma biomarkers representing several different organ systems, tissue beds, and inflammation can identify high-risk neonates undergoing CPB for the ICU-30 composite outcome
Our overall objective is to evaluate the impact of an AI informed CDSS in facilitating safe and timely discontinuation of MV in patients following surgery for CHD.
In this prospective study, our objective is to improve imaging quality for patients with CIEDs by translating existing wideband sequences (developed for adults) into pediatric care.
In our study, we plan to investigate how a new treatment for Fontan patients helps improve the abnormalities in their circulatory system.
The Brett Boyer Foundation is thrilled to announce the funding of a full-time mental health specialist at Vanderbilt focused specifically on the CHD community.
The objective of the project is to determine the minimum level of immune suppression required for partial heart transplants.
The goal of this project is to demonstrate the feasibility of manufacturing such device, evaluate the fixation integrity and investigate the long-term stability of the prototype attachment mechanisms compared to standard leads in a chronic pig study
We seek to develop a first-of-its-kind cardiac output monitoring device to give healthcare teams the power to non-invasively, accurately, and continuously measure and monitor cardiac output in patients with CHD.
Our goal is to improve the lives of patients with CHD by reducing the impact of postoperative thrombosis on mortality, morbidity, and resource utilization.
The purpose is to determine the effect of gut health in post-operative CHD babies on their long-term prognosis and to promote scientific innovation in outcomes research for patients with congenital heart disease.
The goal of this project is to determine how to define the concept of wearability in children – allowing for improved device design as well as improved usability for patients and families.